Literature DB >> 1090755

Escherichia coli capsule bacteriophages. IV. Free capsule depolymerase 29.

W Bessler, F Fehmel, E Freund-Mölbert, H Knüfermann, S Stirm.   

Abstract

The free host capsule depolymerase, induced by Escherichia coli capsule bacteriophage no. 29, and causing the formation of haloes around its plaques, has been purified to homogeneity. As judged from the following facts, this "enzyme" consists of free phage 29 spikes. (i) Detached phage organelles and depolymerase 29 particles exhibit the same molecular weight (about 245,000, as determined from the sedimentation equilibrium), contain polypeptide chains of the same two sizes (57,000 plus or minus 3,000 and 29,500 plus or minus 2,000, as determined by SDS-PAA gel electrophoresis), and have (within experimental error) the same sedimentation coefficient, isoelectric point, and amino acid composition. (ii) Isolated depolymerase and phage spikes in situ both catalyze the hydrolysis of glucosidic bonds in host capsular polysaccharide, leading ultimately to the formation of oligosaccharide fragments of one, two, and three hexasaccharide repeating units. (iii) Depolymerase 29 and phage 29 spikes have roughly the same electron optical dimensions. As tentatively estimated from the total and the virus-associated capsule depolymerase activity in the lysates, phage 29 infection seems to produce eight to seventeen times more free than incorporated spikes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090755      PMCID: PMC354542     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Escherichia coli capsule bacteriophages. III. Fragments of bacteriophage 29.

Authors:  D Rieger; E Freund-Mölbert; S Stirm
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  MOLECULAR EXCLUSION AND RESTRICTED DIFFUSION PROCESSES IN MOLECULAR-SIEVE CHROMATOGRAPHY.

Authors:  G K ACKERS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

3.  An enzyme produced by a phage-host cell system. II. The properties of the polysaccharide depolymerase.

Authors:  M H ADAMS; B H PARK
Journal:  Virology       Date:  1956-12       Impact factor: 3.616

4.  Isolation of spike-formed particles from bacteriophage lysates.

Authors:  S Stirm; W Bessler; F Fehmel; E Freund-Mölbert; H Thurow
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

5.  A bacteriophage-induced depolymerase active on Klebsiella K11 capsular polysaccharide.

Authors:  W Bessler; E Freund-Mölbert; H Knüfermann; C Rduolph; H Thurow; S Stirm
Journal:  Virology       Date:  1973-11       Impact factor: 3.616

6.  Catalytic and molecular properties of a phage-induced capsular polysaccharide depolymerase.

Authors:  E C Yurewicz; M A Ghalambor; D H Duckworth; E C Heath
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

7.  Depolymerases for bacterial exopolysaccharides obtained from phage-infected bacteria.

Authors:  I W Sutherland; J F Wilkinson
Journal:  J Gen Microbiol       Date:  1965-06

8.  ENZYME ASSOCIATED WITH BACTERIOPHAGE INFECTION.

Authors:  C Eklund; O Wyss
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

9.  Immunochemistry of K antigens of Escherichia coli. The K29 antigen of E. coli 09:K29(A):H-.

Authors:  B Jann; K Jann
Journal:  Eur J Biochem       Date:  1971-07-29

10.  Escherichia coli capsule bacteriophages. II. Morphology.

Authors:  S Stirm; E Freund-Mölbert
Journal:  J Virol       Date:  1971-09       Impact factor: 5.103

View more
  11 in total

1.  Escherichia coli capsule bacteriophages. III. Fragments of bacteriophage 29.

Authors:  D Rieger; E Freund-Mölbert; S Stirm
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Escherichia coli capsule bacteriophages. V. Lysozyme 29.

Authors:  H Eichholtz; E Freund-Mölbert; S Stirm
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

3.  Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.

Authors:  James M Regeimbal; Anna C Jacobs; Brendan W Corey; Matthew S Henry; Mitchell G Thompson; Rebecca L Pavlicek; Javier Quinones; Ryan M Hannah; Meron Ghebremedhin; Nicole J Crane; Daniel V Zurawski; Nimfa C Teneza-Mora; Biswajit Biswas; Eric R Hall
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Escherichia coli capsule bacteriophages. IV. Primary structure of the bacteriophage 29 receptor, the E. coli serotype 29 capsular polysaccharide.

Authors:  Y M Choy; F Fehmel; N Frank; S Stirm
Journal:  J Virol       Date:  1975-09       Impact factor: 5.103

5.  Neuraminidase associated with coliphage E that specifically depolymerizes the Escherichia coli K1 capsular polysaccharide.

Authors:  S Tomlinson; P W Taylor
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Characterization of poly-gamma-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-gamma-glutamate.

Authors:  Keitarou Kimura; Yoshifumi Itoh
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

7.  Salmonella bacteriophage glycanases: endorhamnosidases of Salmonella typhimurium bacteriophages.

Authors:  S B Svenson; J Lönngren; N Carlin; A A Lindberg
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

8.  Endo-N-acetylneuraminidase associated with bacteriophage particles.

Authors:  B Kwiatkowski; B Boschek; H Thiele; S Stirm
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

9.  Salmonella bacteriophage glycanases: endorhamnosidase activity of bacteriophages P27, 9NA, and KB1.

Authors:  R Wollin; U Eriksson; A A Lindberg
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

10.  Synergy as a rationale for phage therapy using phage cocktails.

Authors:  Matthew Schmerer; Ian J Molineux; James J Bull
Journal:  PeerJ       Date:  2014-09-25       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.